ArticleBlood cancer journal2021

Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation.

Madlen Jentzsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.